Lv3
250 积分 2025-11-22 加入
232eP Preoperative short-course radiotherapy combined with tislelizumab followed by sequential immunotherapy combined with chemotherapy for locally advanced rectal cancer: A single-center phase II study
10天前
已关闭
Neoadjuvant chemoradiation with or without PD-1 blockade in locally advanced rectal cancer: a randomized phase 2 trial
14天前
已完结
Short-course-based TNT with or without PD-1 inhibitor for pMMR locally advanced rectal cancer: Phase 2 results of a randomized trial (STELLAR II)
14天前
已完结
Impact of PD1 blockade added to neoadjuvant chemoradiotherapy on rectal cancer surgery: post-hoc analysis of the randomized POLARSTAR trial
14天前
已完结
The immune microenvironment of colorectal cancer
1个月前
已完结
Neoadjuvant Immunotherapy Alone for Patients With Locally Advanced and Resectable Metastatic Colorectal Cancer of dMMR/MSI-H Status
1个月前
已完结
Nivolumab plus Ipilimumab in Microsatellite-Instability–High Metastatic Colorectal Cancer
1个月前
已完结
Neoadjuvant Immune Checkpoint Inhibitor Therapy for Localized Deficient Mismatch Repair Colorectal Cancer
1个月前
已完结
Research Perspective on Effectiveness of Organ Preservation for Locally Advanced Rectal Cancer With Complete Clinical Response After Neoadjuvant Chemoradiotherapy: Bayesian Network Meta-analysis
1个月前
已关闭
Neoadjuvant immunotherapy for mismatch repair-deficient colon cancer: a phase II study
1个月前
已完结
皖公网安备34019202002308
